Other safety alerts
|
| |
| Australia: EVE allylisopropylacetylurea tablets |
| |
Therapeutic Goods Administration (TGA) is warning consumers against taking EVE branded products that contain allylisopropylacetylurea (apronal) as they pose a significant health risk and are prohibited from sale, supply or use in Australia.
Apronal is a hypnotic sedative that was withdrawn from clinical use in Australia due to dangerous side effects and is banned in most countries in the world. It can go by many names including apronalide, ACE, and (2-isopropyl-4-pentenoyl) urea.
Apronal has been found in a range of imported EVE branded products (not registered for use or sale in Australia) declared as allylisopropylacetylurea on the ingredients, including:
- EVE Quick for Headache
- EVE Quick for Headache DX
- EVE A
- EVE A EX
The TGA reminds consumers and businesses that it is illegal to import, advertise or supply unregistered therapeutic goods in Australia. If consumers or someone they care for is taking EVE branded tablets containing allylisopropylacetylurea, stop taking them immediately and take any remaining tablets to their local pharmacy for safe disposal.
Please refer to the following website in TGA for details:
http://www.tga.gov.au/news/safety-alerts/eve-allylisopropylacetylurea-tablets
In Hong Kong, the above products are not registered pharmaceutical products.
Ends/Thursday, Jun 1, 2023
Issued at HKT 14:30
|
| |
